Over the years, Kennedy Krieger’s scientists and researchers have made crucial medical discoveries that have led to innovative treatments and improved patient care for individuals with disorders of the brain, spinal cord and musculoskeletal system.
To learn more about research studies currently recruiting participants, click the links below:
Attention-Deficit/Hyperactivity Disorder (ADHD)
Children, ages 8-12, with and without ADHD
Autism Spectrum and Pervasive Developmental Disorders
Children, ages 4-18 years of age
Children, 8-12 months of age, with no visual or hearing impairments
Help Speed Up Autism Research - Join SPARK Today
Children ages 8-12 with and without autism spectrum disorders
Children and adults ages 5-21 with autism spectrum disorders
Children ages 4.0-12.0 years with autism spectrum disorders
Identical twin sets ages 3-30, boys or girls, either one or both with Autism
Behavioral Disorders/Self Injurious Behavior
Children, ages 2-5 years, who have behavior problems
Bipolar Disoder
Children with Bipolar Disorder
Brain Injury (BI)
Typically Developing Children and Adults, Ages 3-20
Cancer
Concussion
Children aged 10-17 years old with a recent concussion
Children aged 10-17 years old who have never had a concussion
Down Syndrome
Individuals ages 7-17 with Down syndrome (Brochure)
Individuals ages 7-17 with Down syndrome (Flyer)
Children and adolescents ages 10-17 with Down syndrome
Dyslexia
Children, ages 8-12 years, with Dyslexia
Learning Disorders (LD)
Children ages 6-11 years and their parents to participate in a behavior and genetics research study
Children and young adults, age 8-15
Major Depressive Disorder
Muscular Dystrophy
Males with DMD >=4 and <8 years of age
Adults with FSHD and their first degree unaffected relative
Adults with FSHD and their first degree unaffected relative 18 years of age or older
Ambulatory males with DMD 5 -18 years of age
Prematurity
Children aged 6-8 years with and without a history of iron deficiency
Psychiatric Disorders
CLINICAL TRIAL: Investigational Drug for Schizophrenia in Adolescents, Ages 12 to 16
Investigational Drug for Bipolar I Disorder in Children and Adolescents, Ages 10 to 17
CLINICAL TRIAL: Investigational Drug for Schizophrenia in Adolescents, Ages 13 to 17
Rett Syndrome
CLINICAL TRIAL: Children ages 1-9.99 years of age with MECP2 mutation
Sickle Cell Disease
Children, age 8-12, with a diagnosis of sickle cell disease
Sleep Disorders
Slow Moving
Children between the ages of 6 to 11 years who work more slowly than their siblings or peers
Spinal Cord Injury and Paralysis
Adults, age 18-80 with ASIA A-D cervical (C4-C7) injury
Adults, age 18-65 with complete spinal cord injury at any level (ASIA A)
Adults, age 18-65 with spinal cord injury
Adults, age 18-55 with cervical spinal cord injury
Adults, age 18-55 with spinal cord injury who want to learn how to sail
Sturge-Weber Syndrome (SWS)
Sirolimus Research Study for Cognitive Impairments in Sturge-Weber syndrome
SYNGAP1 Mutations
Tourette Syndrome (TS):
Children, aged 8-12 years with and without Tourette Syndrome
Tuberous Sclerosis Complex (TSC)
CLINICAL TRIALS:Children ages 4-15 years with Tuberous Sclerosis Complex, autism, and seizures
CLINICAL TRIAL: Tuberous Sclerosis (TSC) patients of all ages with visible facial angiofibromas